Company Profiles

driven by the PitchBook Platform

Excelimmune

Description

Operator of a bio-pharmaceutical company designed to leverage the diversity, specificity and power of the human body's natural immune system. The company's pharmaceutical includes discovery and development of antibody combination therapeutics, enabling infectious diseases, protein diseases and cancer.

2006

Founded

PRIVATE

Status

1-10

Employees

Debt

Latest Deal Type

$6M

Latest Deal Amount

$14.5M

Total Amount Raised

Description

Operator of a bio-pharmaceutical company designed to leverage the diversity, specificity and power of the human body's natural immune system. The company's pharmaceutical includes discovery and development of antibody combination therapeutics, enabling infectious diseases, protein diseases and cancer.

Website:

www.excelimmune.com

Ownership Status

Privately held (backing)

Financing Status

Venture Capital-Backed

Primary Industry

Drug Discovery

Other Industries

Biotechnology

Primary Office

1776 Massachusetts Avenue Lexington, MA 02420United States +1 (781) 262-8055
Request a free trial to the PitchBook Platform
You're viewing a free company profile from the PitchBook Platform. To explore Excelimmune's full profile, request a free trial.

Excelimmune Valuation and Funding

Request access
Deal TypeDateAmountRaised to DatePost-ValStatusStage

Excelimmune Cap Table

Stock# of Shares
Authorized
Par ValueDividend Rate (%)Original
Issue Price
LiquidationLiquidation
Pref. Multiple
Conversion
Price
% Owned

Excelimmune Investors (3)

Request access
Investor NameInvestor TypeHoldingInvestor SinceParticipating RoundsBoard
Seat
Contact
Info
David JeskeAngel (individual)Minority000 0000000 0000
GreenheartVenture CapitalMinority000 0000000 0000
Individual InvestorAngel (individual)Minority000 0000000 0000
David Jeske Angel (individual)
Greenheart Venture Capital
Individual Investor Angel (individual)

Excelimmune Executive Team (2)

NameTitleBoard
Seat
Contact
Info
Thomas Dahl Ph.DVice President, Product Development
Jason WalshChief Financial Officer & Vice President, Corporate Development
Thomas Dahl Ph.D Vice President, Product Development
Jason Walsh Chief Financial Officer & Vice President, Corporate Development

Excelimmune Board Members (1)

NameRepresentingRoleSinceContact
Info
Mark De Souza Ph.DSelfDirector000 0000
Mark De Souza Ph.D Director Self
Request full access to PitchBook